GRN and metabolic disease: Furthermore, targeted regulation of PGRN has been shown to suppress inflammation (directly or indirectly induced), promote cartilage repair, modulate bone remodelling, restore OB-OC equilibrium, and maintain bone homeostasis, thereby offering therapeutic benefits for these metabolic disorders.